Immediate Impact
50 standout
Citing Papers
Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications
2025 Standout
Pancreatic cancer
2025 Standout
Works of Yiwen Chen being referenced
Randomized phase III study of sintilimab in combination with modified folfrinox versus folfrinox alone in patients with metastatic and recurrent pancreatic cancer in China: The CISPD3 trial.
2022
A Neurorobotics Simulation of Autistic Behavior Induced by Unusual Sensory Precision
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yiwen Chen | 141 | 43 | 49 | 69 | 68 | 32 | 367 | |
| Valerio Basile | 25 | 24 | 38 | 42 | 47 | 37 | 411 | |
| E Martin | 85 | 23 | 33 | 32 | 30 | 22 | 323 | |
| Takehiro Maki | 116 | 18 | 8 | 19 | 93 | 27 | 335 | |
| Weibo Liu | 44 | 48 | 11 | 79 | 15 | 36 | 405 | |
| Qingping Zhang | 38 | 51 | 19 | 24 | 17 | 47 | 354 | |
| Giuseppe Galvani | 36 | 11 | 24 | 27 | 43 | 22 | 343 | |
| Sumiko Magari | 40 | 25 | 30 | 23 | 42 | 25 | 362 | |
| Liangliang Meng | 49 | 61 | 9 | 147 | 28 | 23 | 348 | |
| Yi Zhang | 39 | 85 | 21 | 37 | 10 | 43 | 408 | |
| Tao Chen | 52 | 31 | 4 | 39 | 74 | 31 | 405 |
All Works
Login with ORCID to disown or claim papers
Loading papers...